Tag: Survival

Improved survival seen with structured program in patients with resected colon cancer who have completed adjuvant chemo

Progression-free survival longer with vepdegestrant than fulvestrant in subgroup with ESR1 mutations, but not in the overall population

Clinically relevant but not statistically significant improvement seen in anxiety and fatigue versus usual services

Racial differences in treatment common, including lower likelihood of surgery for stage I to II lung cancer in Black patients

Engaging in leisure-time MVPA linked to improved survival for various cancer types including bladder, breast, colon

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy

REM inhibition via receipt of antidepressant medications associated with trend toward survival benefit

Risk of death remained similar following simple hysterectomy versus other types of hysterectomy in adjusted analyses